Rhelion Life Sciences Corp. (CSE:RHEL)

Rhelion Life Sciences Revenue

Rhelion Life Sciences had revenue of 186.07K CAD in the quarter ending June 30, 2026, a decrease of -66.35%. This brings the company's total for the last twelve months to 3.83M, down -2.80% year-over-year. In the fiscal year ending March 31, 2026, Rhelion Life Sciences had annual revenue of 4.20M, down -15.15%. That makes Rhelion Life Sciences the 41,689th largest company in the world by revenue and 809th in Canada.

• Revenue (ttm): 3.83M
• Revenue Growth: -2.80%
• P/S Ratio: 3.21
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 12.28M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Netherlands 3.34M 79.5%
• Canada 860.06K 20.5%
• USA 117.00 0.0%

Fiscal year ended Mar 31, 2026 See the full Rhelion Life Sciences breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	4.20M	-749.01K	-15.15%
Mar 31, 2025	4.94M	192.40K	4.05%
Mar 31, 2024	4.75M	802.31K	20.31%
Mar 31, 2023	3.95M	1.62M	69.84%
Mar 31, 2022	2.33M	2.21M	1,995.96%

Data Source: S&P Global Market Intelligence Last updated: Aug 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 30, 2026

Data Sources Report a data error